戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 en play a crucial role in the development of pseudoachondroplasia.
2 ts and COOH-terminal globular region lead to pseudoachondroplasia.
3 e critical cellular and clinical features of pseudoachondroplasia.
4 ge oligomeric matrix protein (COMP) leads to pseudoachondroplasia, a skeletal abnormality.
5 indings suggest that the secretory defect in pseudoachondroplasia and multiple epiphyseal dysplasia i
6 sociated with two human skeletal dysplasias, pseudoachondroplasia and multiple epiphyseal dysplasia,
7 xtracellular matrix, have been identified in pseudoachondroplasia and multiple epiphyseal dysplasia,
8 eoarthritis (OA) are phenotypes of inherited pseudoachondroplasia and multiple epiphyseal dysplasia.
9  gene have been linked to the development of pseudoachondroplasia and multiple epiphyseal dysplasia.
10 gene to the 4, 6 or 7mers in the etiology of pseudoachondroplasia and multiple epiphyseal dysplasia.
11 tein (COMP) lead to two skeletal dysplasias, pseudoachondroplasia and multiple epiphyseal dysplasia.
12             Mutations in the COMP gene cause pseudoachondroplasia and multiple epiphyseal dysplasia.
13 SP5 mutations cause two skeletal dysplasias, pseudoachondroplasia and multiple epiphyseal dysplasia;
14 COMP) have been linked to the development of pseudoachondroplasia and multiple epiphyseal dysplasia;
15 hanisms underlying D469del-COMP pathology in pseudoachondroplasia and suggest that oxidative stress a
16 signated MUT3 that accounts for 30% of human pseudoachondroplasia cases, to determine if the mutation
17 tion of D469del-COMP, thereby recapitulating pseudoachondroplasia chondrocyte pathology.
18 erlying the murine mutant (MT)-COMP model of pseudoachondroplasia, increased midline-1 (MID1) express
19 rocytes by necroptosis was also found in our pseudoachondroplasia mouse model.
20 OMP and the most common mutant form found in pseudoachondroplasia, MUT3, using a mammalian expression
21 tions in COMP cause two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dys
22                                              Pseudoachondroplasia (PSACH) and multiple epiphyseal dys
23 rotein (COMP) cause two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dys
24                            Chondrocytes from pseudoachondroplasia (PSACH) and multiple epiphyseal dys
25                                              Pseudoachondroplasia (PSACH) and multiple epiphyseal dys
26                                              Pseudoachondroplasia (PSACH) and multiple epiphyseal dys
27                                              Pseudoachondroplasia (PSACH) is one of the more common s
28 ve identified a novel missense mutation in a pseudoachondroplasia (PSACH) patient in one of the type
29             Mutations in the COMP gene cause pseudoachondroplasia (PSACH), a severe dwarfing conditio
30                                              Pseudoachondroplasia (PSACH), a severe short-limb dwarfi
31  for multiple epiphyseal dysplasia (MED) and pseudoachondroplasia (PSACH).
32  oligomeric matrix protein gene (COMP) cause pseudoachondroplasia (PSACH).
33 COMP previously identified in a patient with pseudoachondroplasia resulted in abnormal sequestration